Optimal primary surgical treatment for advanced epithelial ovarian cancer
A Elattar, A Bryant, BA Winter‐Roach… - Cochrane database …, 2011 - cochranelibrary.com
Background Ovarian cancer is the sixth most common cancer among women. In addition to
diagnosis and staging, primary surgery is performed to achieve optimal cytoreduction …
diagnosis and staging, primary surgery is performed to achieve optimal cytoreduction …
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
SL Coleridge, A Bryant, S Kehoe… - Cochrane Database of …, 2021 - cochranelibrary.com
Background Epithelial ovarian cancer presents at an advanced stage in the majority of
women. These women require surgery and chemotherapy for optimal treatment …
women. These women require surgery and chemotherapy for optimal treatment …
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis
RE Bristow, RS Tomacruz, DK Armstrong… - Journal of clinical …, 2002 - ascopubs.org
PURPOSE: To evaluate the relative effect of percent maximal cytoreductive surgery and
other prognostic variables on survival among cohorts of patients with advanced-stage …
other prognostic variables on survival among cohorts of patients with advanced-stage …
Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis
SJ Chang, M Hodeib, J Chang, RE Bristow - Gynecologic oncology, 2013 - Elsevier
Objective To quantify the impact of complete cytoreduction to no gross residual disease on
overall survival among patients with advanced-stage ovarian cancer treated during the …
overall survival among patients with advanced-stage ovarian cancer treated during the …
Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis
RE Bristow, I Puri, DS Chi - Gynecologic oncology, 2009 - Elsevier
OBJECTIVE: To determine the relative effect of multiple prognostic variables on overall post-
recurrence survival time among cohorts of patients with recurrent ovarian cancer undergoing …
recurrence survival time among cohorts of patients with recurrent ovarian cancer undergoing …
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis
RE Bristow, DS Chi - Gynecologic oncology, 2006 - Elsevier
OBJECTIVE: To determine the overall survival and relative effect of multiple prognostic
variables in cohorts of patients with advanced-stage ovarian cancer treated with platinum …
variables in cohorts of patients with advanced-stage ovarian cancer treated with platinum …
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery
Background Ovarian cancer is the seventh most common cancer among women and a
leading cause of death from gynaecological malignancies. Epithelial ovarian cancer is the …
leading cause of death from gynaecological malignancies. Epithelial ovarian cancer is the …
Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients
I Vergote, I De Wever, W Tjalma, M Van Gramberen… - Gynecologic …, 1998 - Elsevier
Objective. This study was aimed at comparison of neoadjuvant chemotherapy with primary
debulking surgery in advanced ovarian carcinoma. Methods. Retrospective analysis of 285 …
debulking surgery in advanced ovarian carcinoma. Methods. Retrospective analysis of 285 …
Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma
MJA Engelen, HE Kos, PHB Willemse… - … Journal of the …, 2006 - Wiley Online Library
BACKGROUND Consultant gynecologic oncologists from the regional Comprehensive
Cancer Center assisted community gynecologists in the surgical treatment of patients with …
Cancer Center assisted community gynecologists in the surgical treatment of patients with …
Cancer of the ovary
SA Cannistra - New England Journal of Medicine, 1993 - Mass Medical Soc
Epithelial cancer of the ovary is the fifth most common malignant condition among women in
the United States, with an annual incidence of 22,000 new cases1. This disease …
the United States, with an annual incidence of 22,000 new cases1. This disease …